Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-0843

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy ; volume:72 ; number:6 ; day:12 ; month:10 ; year:2013 ; pages:1283-1290 ; date:12.2013
Cancer chemotherapy and pharmacology ; 72, Heft 6 (12.10.2013), 1283-1290, 12.2013

Creator: Kono, Toru
Hata, Taishi
Morita, Satoshi
Munemoto, Yoshinori
Matsui, Takanori
Kojima, Hiroshi
Takemoto, Hiroyoshi
Fukunaga, Mutsumi
Nagata, Naoki
Shimada, Mitsuo
Sakamoto, Junichi
Mishima, Hideyuki

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00280-013-2306-7

URN: urn:nbn:de:101:1-2019101403370667353329

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kono, Toru
Hata, Taishi
Morita, Satoshi
Munemoto, Yoshinori
Matsui, Takanori
Kojima, Hiroshi
Takemoto, Hiroyoshi
Fukunaga, Mutsumi
Nagata, Naoki
Shimada, Mitsuo
Sakamoto, Junichi
Mishima, Hideyuki
SpringerLink (Online service)

Other Objects (12)

Oxaliplatin neurotoxicity – no general ion channel surface-charge effect

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence

Oxaliplatin neurotoxicity – no general ion channel surface-charge effect

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence

Oxaliplatin neurotoxicity – no general ion channel surface-charge effect

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Oxaliplatin neurotoxicity – no general ion channel surface-charge effect

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence

Oxaliplatin neurotoxicity – no general ion channel surface-charge effect

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence

Oxaliplatin neurotoxicity – no general ion channel surface-charge effect

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence

Related objects

Reset password